In laboratory research, GHK-Cu is utilized in gene expression profiling experiments (documented effects on 4,000+ human genes), extracellular matrix research gene expression studies (collagen I, III, IV), matrix metalloproteinase (MMP-1, MMP-2, MMP-9) and TIMP regulation assays, glycosaminoglycan deposition measurements, decorin and integrin expression studies, superoxide dismutase (SOD) activity assays, and investigations of VEGF, FGF-2 expression modulation
The highest dose produced weight loss comparable to liraglutide 3.0 mg, establishing cagrilintide as the first long-acting amylin analog to demonstrate clinically meaningful weight reduction in a randomized trial
10.1073/pnas.0900206106 87 MehtaV.MeenaJ.KasanaH.MunshiA.ChanderH
Kostyuk, V
Quality of life for patients with obsessive-compulsive disorder